The STAT3-IGFBP5 axis is critical for IL-6/gp130-induced premature senescence in human fibroblasts

Cell Cycle

Volumn 11, Issue 4, 2012, Pages 730-739

  Kojima, Hirotada ^a   Kunimoto, Hiroyuki ^a   Inoue, Toshiaki ^b   Nakajima, Koichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cellular senescence; Cytokine; IGFBP5; Interleukin 6; STAT3

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN 5; STAT3 PROTEIN;

ARTICLE; CELL AGING; CELL STIMULATION; DNA DAMAGE; FIBROBLAST; HUMAN; HUMAN CELL;

EID: 84857472970     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.11.4.19172     Document Type: Article

References (49)

1. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS. The essence of senescence. Genes Dev 2010; 24:2463-79; PMID:21078816; http://dx.doi.org/10.1101/gad. 1971610.
2. Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011; 192:547-56; PMID:21321098; http:// dx.doi.org/10.1083/jcb.201009094.
3. Sikora E, Arendt T, Bennett M, Narita M. Impact of cellular senescence signature on ageing research. Ageing Res Rev 2011; 10:146-52; PMID:20946972; http://dx.doi.org/10.1016/j.arr.2010.10.002.
4. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25:585-621; PMID: 13905659; http://dx.doi. org/10.1016/0014-4827(61)90192-6.
5. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003; 426:194-8; PMID:14608368; http://dx.doi.org/10.1038/ nature02118.
6. Toussaint O, Dumont P, Dierick JF, Pascal T, Frippiat C, Chainiaux F, et al. Stress-induced premature senescence. Essence of life, evolution, stress and aging. Ann NY Acad Sci 2000; 908:85-98; PMID:10911950; http://dx.doi.org/10. 1111/j.1749-6632.2000.tb06638.x.
7. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997; 88:593-602; PMID:9054499; http://dx.doi. org/10.1016/S0092-8674(00) 81902-9.
8. Serrano M, Blasco MA. Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 2007; 8:715-22; PMID:17717516; http://dx.doi. org/10.1038/nrm2242.
9. Courtois-Cox S, Jones SL, Cichowski K. Many roads lead to oncogene-induced senescence. Oncogene 2008; 27:2801-9; PMID:18193093; http://dx.doi. org/10.1038/sj.onc.1210950.
10. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10. 1038/nature05327.
11. Toledo LI, Murga M, Gutierrez-Martinez P, Soria R, Fernandez-Capetillo O. ATR signaling can drive cells into senescence in the absence of DNA breaks. Genes Dev 2008; 22:297-302; PMID:18245444; http:// dx.doi.org/10.1101/gad. 452308.
12. Wajapeyee N, Wang SZ, Serra RW, Solomon PD, Nagarajan A, Zhu X, et al. Senescence induction in human fibroblasts and hematopoietic progenitors by leukemogenic fusion proteins. Blood 2010; 115:5057-60; PMID:20421454; http://dx.doi.org/10.1182/ blood-2009-09-245928.
13. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7; PMID:7568133; http://dx.doi.org/ 10.1073/pnas.92.20.9363.
14. Moiseeva O, Mallette FA, Mukhopadhyay UK, Moores A, Ferbeyre G. DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation. Mol Biol Cell 2006; 17:1583-92; PMID:16436515; http://dx.doi.org/ 10.1091/mbc. E05-09-0858.
15. Kim KS, Kang KW, Seu YB, Baek SH, Kim JR. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech Ageing Dev 2009; 130:179-88; PMID:19071156; http://dx.doi.org/10.1016/j. mad.2008.11.004.
16. Frippiat C, Chen QM, Zdanov S, Magalhaes JP, Remacle J, Toussaint O. Subcytotoxic H2O2 stress triggers a release of transforming growth factorbeta1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem 2001; 276:2531-7; PMID:11060295; http://dx.doi. org/10.1074/jbc. M006809200.
17. Debacq-Chainiaux F, Pascal T, Boilan E, Bastin C, Bauwens E, Toussaint O. Screening of senescence-associated genes with specific DNA array reveals the role of IGFBP-3 in premature senescence of human diploid fibroblasts. Free Radic Biol Med 2008; 44:1817-32; PMID:18329388; http://dx.doi.org/10.1016/j. freeradbiomed. 2008.02.001.
18. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, et al. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell 2007; 18:4543-52; PMID:17804819; http://dx.doi.org/10.1091/mbc. E07-03-0280.
19. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132:363-74; PMID:18267069; http://dx.doi.org/10.1016/ j.cell.2007.12.032.
20. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133:1006-18; PMID:18555777; http://dx.doi. org/10.1016/j.cell.2008.03.038.
21. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6:2853-68; PMID:19053174; http://dx.doi. org/10.1371/journal.pbio.0060301.
22. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9:81-94; PMID:19132009; http://dx.doi.org/10.1038/ nrc2560.
23. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van Doorn R, Desmet CJ, et al. Oncogeneinduced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133:1019-31; PMID:18555778; http://dx.doi.org/10.1016/j. cell.2008.03.039.
24. Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev 1997; 8:241-52; PMID:9620640; http://dx.doi.org/10.1016/S1359-6101(98)80005-1.
25. Hirano T, Ishihara K, Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19:2548-56; PMID:10851053; http://dx.doi.org/10.1038/sj.onc.1203551.
26. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, et al. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58:573-81; PMID:2788034; http://dx.doi.org/10. 1016/0092-8674(89)90438-8.
27. Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol 2011; 90:484-94; PMID:21145125; http://dx.doi. org/10.1016/j.ejcb. 2010.10.007.
28. Ershler WB, Keller ET. Age-associated increased interleukin- 6 gene expression, late-life diseases and frailty. Annu Rev Med 2000; 51:245-70; PMID:10774463; http://dx.doi.org/10.1146/annurev.med.51.1.245.
29. Jones SA, Horiuchi S, Topley N, Yamamoto N, Fuller GM. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J 2001; 15:43-58; PMID:11149892; http://dx.doi.org/10.1096/fj.99-1003rev.
30. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, Glaser R. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 2003; 100:9090-5; PMID:12840146; http://dx.doi.org/10.1073/ pnas.1531903100.
31. Maggio M, Basaria S, Ble A, Lauretani F, Bandinelli S, Ceda GP, et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab 2006; 91:345- 7; PMID:16263825; http://dx.doi.org/10.1210/ jc.2005-1097.
32. Niu G, Wright KL, Ma Y, Wright GM, Huang M, Irby R, et al. Role of Stat3 in regulating p53 expression and function. Mol Cell Biol 2005; 25:7432- 40; PMID:16107692; http://dx.doi.org/10.1128/ MCB.25.17.7432-40.2005.
33. Campisi J. Senescent cells, tumor suppression and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22; PMID:15734683; http://dx.doi. org/10.1016/j.cell.2005.02.003.
34. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000; 10:886-95; PMID:10959836; http://dx.doi.org/10.1016/S0960-9822(00)00610-2.
35. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996; 15:3651-8; PMID:8670868.
36. Abe K, Hirai M, Mizuno K, Higashi N, Sekimoto T, Miki T, et al. The YXXQ motif in gp 130 is crucial for STAT3 phosphorylation at Ser727 through an H7-sensitive kinase pathway. Oncogene 2001; 20:3464-74; PMID:11429693; http://dx.doi. org/10.1038/sj.onc.1204461.
37. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV, Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle 2009; 8:4112-8; PMID:19946210; http://dx.doi. org/10.4161/cc.8.24.10215.
38. Leontieva OV, Gudkov AV, Blagosklonny MV. Weak p53 permits senescence during cell cycle arrest. Cell Cycle 2010; 9:4323-7; PMID:21051933; http://dx.doi.org/10.4161/cc.9.21.13584.
39. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344-52; PMID:20606252.
40. Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660-4; PMID:20457898; http://dx.doi.org/10.1073/pnas.1002298107.
41. Blagosklonny MV. Cell cycle arrest is not senescence. Aging (Albany NY) 2011; 3:94-101; PMID:21297220.
42. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, et al. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009; 11:973- 9; PMID:19597488; http://dx.doi.org/10.1038/ncb1909.
43. Freund A, Patil CK, Campisi J. p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype. EMBO J 2011; 30:1536-48; PMID:21399611; http://dx.doi. org/10.1038/emboj.2011. 69.
44. Beattie J, Allan GJ, Lochrie JD, Flint DJ. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 2006; 395:1-19; PMID:16526944; http://dx.doi.org/10.1042/ BJ20060086.
45. Chapman RS, Lourenco PC, Tonner E, Flint DJ, Selbert S, Takeda K, et al. Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev 1999; 13:2604-16; PMID:10521404; http://dx.doi.org/10.1101/gad.13.19.2604.
46. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 2009; 9:798-809; PMID:19851315; http://dx.doi.org/10.1038/nrc2734.
47. Daynes RA, Araneo BA, Ershler WB, Maloney C, Li GZ, Ryu SY. Altered regulation of IL6 production with normal aging. Possible linkage to the ageassociated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol 1993; 150:5219-30; PMID:8515056.
48. Kojima H, Sasaki T, Ishitani T, Iemura S, Zhao H, Kaneko S, et al. STAT3 regulates Nemo-like kinase by mediating its interaction with IL6-stimulated TGFbeta-activated kinase 1 for STAT3 Ser-727 phosphorylation. Proc Natl Acad Sci USA 2005; 102:4524-9; PMID:15764709; http://dx.doi.org/10.1073/pnas.0500679102.
49. Kojima H, Nakajima K, Hirano T. IL6-inducible complexes on an IL6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s). Oncogene 1996; 12:547-54; PMID:8637711.